Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label exploratory study of regadenoson bolus for pharmacological stress echocardiography
2008-003839-20Phase 2Terminated
- Sponsor
- Gilead Sciences
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of regadenoson in coronary arteriosclerosis (5 arms), sponsored by Gilead Sciences. Primary endpoints: Primary completion of evaluable echocardiograms, Efficacy of regadenoson for stress echocardiography and 1 more. Started Jul 2008; status: terminated.
02
Drugs
regadenoson
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-003839-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003839-20.